Back to all cases
FDA
🇺🇸 United States·2025
Collected
DBRPharmaceuticals
Case Summary
The FDA's 21 CFR Part 211 and EudraLex Volume 4 guidelines ensure strict quality, safety, and efficacy standards in pharmaceutical manufacturing.
Source
- Title
- The Impact of Current Good Manufacturing Practices Inspections on Continuous Improvement Mindset in the Pharmaceutical Industry
- Type
- academic paper
- Year
- 2025
- Confidence Score
- 80%